FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3036902016> ?p ?o ?g. }

• W3036902016 endingPage "101765" @default.
• W3036902016 startingPage "101765" @default.
• W3036902016 abstract "Cipargamin (KAE609) is a novel spiroindolone class drug for the treatment of malaria, currently undergoing phase 2 clinical development. This review provides an overview and interpretation of the pre-clinical and clinical data of this possible next-generation antimalarial drug published to date. We systematically searched the literature for studies on the preclinical and clinical development of cipargamin. PubMed and Google Scholar databases were searched using the terms ‘cipargamin’, ‘KAE609ʹ or ‘NITD609’ in the English language; one additional article was identified during revision. Nineteen of these in total 43 papers identified reported original studies; 13 of those articles were on pre-clinical studies and 6 reported clinical trials. A total of 20 studies addressing its preclinical and clinical development have been published on this compound at the time of writing. Cipargamin acts on the PfATP4, which is a P-type Na + ATPase disrupting the Na + homeostasis in the parasite. Cipargamin is a very fast-acting antimalarial, it is active against all intra-erythrocytic stages of the malaria parasite and exerts gametocytocidal activity, with transmission-blocking potential. It is currently undergoing phase 2 clinical trial to assess safety and efficacy, with a special focus on hepatic safety. In the search for novel antimalarial drugs, cipargamin exhibits promising properties, exerting activity against multiple intra-erythrocytic stages of plasmodia, including gametocytes. It exhibits a favourable pharmacokinetic profile, possibly allowing for single-dose treatment with a suitable combination partner. According to the clinical results of the first studies in Asian malaria patients, a possible safety concern is hepatotoxicity." @default.
• W3036902016 created "2020-06-25" @default.
• W3036902016 creator A5006109092 @default.
• W3036902016 creator A5009319293 @default.
• W3036902016 creator A5013340768 @default.
• W3036902016 creator A5026977192 @default.
• W3036902016 creator A5037935339 @default.
• W3036902016 creator A5087477162 @default.
• W3036902016 date "2020-07-01" @default.
• W3036902016 modified "2023-10-14" @default.
• W3036902016 title "The early preclinical and clinical development of cipargamin (KAE609), a novel antimalarial compound" @default.
• W3036902016 cites W1936655088 @default.
• W3036902016 cites W1965250537 @default.
• W3036902016 cites W1970563327 @default.
• W3036902016 cites W2014429457 @default.
• W3036902016 cites W2015251548 @default.
• W3036902016 cites W2046922788 @default.
• W3036902016 cites W2050515661 @default.
• W3036902016 cites W2050622314 @default.
• W3036902016 cites W2055394098 @default.
• W3036902016 cites W2064093461 @default.
• W3036902016 cites W2076198397 @default.
• W3036902016 cites W2081062034 @default.
• W3036902016 cites W2094649888 @default.
• W3036902016 cites W2095062799 @default.
• W3036902016 cites W2138915221 @default.
• W3036902016 cites W2143048218 @default.
• W3036902016 cites W2154313767 @default.
• W3036902016 cites W2156342760 @default.
• W3036902016 cites W2158550819 @default.
• W3036902016 cites W2278582239 @default.
• W3036902016 cites W2278828324 @default.
• W3036902016 cites W2314579490 @default.
• W3036902016 cites W2415374974 @default.
• W3036902016 cites W2432984814 @default.
• W3036902016 cites W2549588172 @default.
• W3036902016 cites W2762238273 @default.
• W3036902016 cites W2771861976 @default.
• W3036902016 cites W2774127531 @default.
• W3036902016 cites W2790773491 @default.
• W3036902016 cites W2790803998 @default.
• W3036902016 cites W2792482579 @default.
• W3036902016 cites W2860893811 @default.
• W3036902016 cites W2885936995 @default.
• W3036902016 cites W2888010211 @default.
• W3036902016 cites W2892375818 @default.
• W3036902016 cites W2913908235 @default.
• W3036902016 cites W2970688720 @default.
• W3036902016 cites W3017330403 @default.
• W3036902016 cites W4385786843 @default.
• W3036902016 doi "https://doi.org/10.1016/j.tmaid.2020.101765" @default.
• W3036902016 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32561392" @default.
• W3036902016 hasPublicationYear "2020" @default.
• W3036902016 type Work @default.
• W3036902016 sameAs 3036902016 @default.
• W3036902016 citedByCount "25" @default.
• W3036902016 countsByYear W30369020162020 @default.
• W3036902016 countsByYear W30369020162021 @default.
• W3036902016 countsByYear W30369020162022 @default.
• W3036902016 countsByYear W30369020162023 @default.
• W3036902016 crossrefType "journal-article" @default.
• W3036902016 hasAuthorship W3036902016A5006109092 @default.
• W3036902016 hasAuthorship W3036902016A5009319293 @default.
• W3036902016 hasAuthorship W3036902016A5013340768 @default.
• W3036902016 hasAuthorship W3036902016A5026977192 @default.
• W3036902016 hasAuthorship W3036902016A5037935339 @default.
• W3036902016 hasAuthorship W3036902016A5087477162 @default.
• W3036902016 hasBestOaLocation W30369020161 @default.
• W3036902016 hasConcept C126322002 @default.
• W3036902016 hasConcept C148482608 @default.
• W3036902016 hasConcept C177713679 @default.
• W3036902016 hasConcept C203014093 @default.
• W3036902016 hasConcept C2778048844 @default.
• W3036902016 hasConcept C2778371730 @default.
• W3036902016 hasConcept C2780035454 @default.
• W3036902016 hasConcept C2908859342 @default.
• W3036902016 hasConcept C502991105 @default.
• W3036902016 hasConcept C535046627 @default.
• W3036902016 hasConcept C64903051 @default.
• W3036902016 hasConcept C71924100 @default.
• W3036902016 hasConcept C98274493 @default.
• W3036902016 hasConcept C99389464 @default.
• W3036902016 hasConceptScore W3036902016C126322002 @default.
• W3036902016 hasConceptScore W3036902016C148482608 @default.
• W3036902016 hasConceptScore W3036902016C177713679 @default.
• W3036902016 hasConceptScore W3036902016C203014093 @default.
• W3036902016 hasConceptScore W3036902016C2778048844 @default.
• W3036902016 hasConceptScore W3036902016C2778371730 @default.
• W3036902016 hasConceptScore W3036902016C2780035454 @default.
• W3036902016 hasConceptScore W3036902016C2908859342 @default.
• W3036902016 hasConceptScore W3036902016C502991105 @default.
• W3036902016 hasConceptScore W3036902016C535046627 @default.
• W3036902016 hasConceptScore W3036902016C64903051 @default.
• W3036902016 hasConceptScore W3036902016C71924100 @default.
• W3036902016 hasConceptScore W3036902016C98274493 @default.
• W3036902016 hasConceptScore W3036902016C99389464 @default.
• W3036902016 hasLocation W30369020161 @default.
• W3036902016 hasOpenAccess W3036902016 @default.

• next